Literature DB >> 24829291

Magnetic resonance imaging in neuromyelitis optica.

George Tackley1, Wilhelm Kuker1, Jacqueline Palace2.   

Abstract

Neuromyelitis optica (NMO), or Devic's disease, is a rare demyelinating disorder of the central nervous system that has a predilection for the optic nerve and spinal cord. Magnetic resonance imaging (MRI) is required to diagnose NMO. Longitudinally extensive transverse myelitis is NMO's imaging hallmark and the presence of a brain MRI that is not diagnostic of multiple sclerosis (MS) also remains part of the diagnostic criteria. It is increasingly recognised that MS and NMO brain imaging can, however, have similar appearances but differences do exist: hypothalamic, periaqueductal grey and area postrema lesions implicate NMO whilst cortical, U-fibre or Dawson's finger lesions are suggestive of MS. The timing of image acquisition, age, ethnicity and aquaporin-4 antibody status are all likely to alter the findings at MRI. This review therefore aims to overview and update the reader on NMO imaging, to provide clinically relevant guidance for diagnosing NMO and differentiating it from MS in order to guide management, and to highlight recent research insights.
© The Author(s), 2014.

Entities:  

Keywords:  Devic’s disease; Magnetic resonance imaging; T2 lesions; demyelination; multiple sclerosis; neuromyelitis optica

Mesh:

Year:  2014        PMID: 24829291     DOI: 10.1177/1352458514531087

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  16 in total

Review 1.  Differential Diagnosis of Acute Myelopathies: An Update.

Authors:  M Nichtweiß; S Weidauer
Journal:  Clin Neuroradiol       Date:  2015-06-02       Impact factor: 3.649

2.  Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.

Authors:  Yaou Liu; Yunyun Duan; Jing Huang; Zhuoqiong Ren; Zheng Liu; Huiqing Dong; Florian Weiler; Horst K Hahn; Fu-Dong Shi; Helmut Butzkueven; Frederik Barkhof; Kuncheng Li
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

3.  Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.

Authors:  Sanjeev Chawla; Yulin Ge; Jens Wuerfel; Shadi Asadollahi; Suyash Mohan; Friedemann Paul; Tim Sinnecker; Ilya Kister
Journal:  Mult Scler Relat Disord       Date:  2020-03-25       Impact factor: 4.339

4.  Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.

Authors:  Carsten Finke; Hanna Zimmermann; Florence Pache; Frederike C Oertel; Velina Sevdalinova Chavarro; Yelyzaveta Kramarenko; Judith Bellmann-Strobl; Klemens Ruprecht; Alexander U Brandt; Friedemann Paul
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

5.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

6.  Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders.

Authors:  Edgar Carnero Contentti; Vanessa Daccach Marques; Ibis Soto de Castillo; Verónica Tkachuk; Amilton Antunes Barreira; Elizabeth Armas; Edson Chiganer; Camila de Aquino Cruz; José Luis Di Pace; Javier Pablo Hryb; Carolina Lavigne Moreira; Carmen Lessa; Omaira Molina; Mónica Perassolo; Arnoldo Soto; Alejandro Caride
Journal:  Spinal Cord       Date:  2018-05-22       Impact factor: 2.772

7.  Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.

Authors:  Yeliz Pekcevik; Charles H Mitchell; Maureen A Mealy; Gunes Orman; In H Lee; Scott D Newsome; Carol B Thompson; Carlos A Pardo; Peter A Calabresi; Michael Levy; Izlem Izbudak
Journal:  Mult Scler       Date:  2015-07-24       Impact factor: 6.312

8.  Reduced apparent diffusion coefficient in neuromyelitis optica-associated optic neuropathy.

Authors:  Jonathan C Horton; Vanja C Douglas; Soonmee Cha
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

Review 9.  What do we know about brain contrast enhancement patterns in neuromyelitis optica?

Authors:  Yeliz Pekcevik; Gunes Orman; In Ho Lee; Maureen A Mealy; Michael Levy; Izlem Izbudak
Journal:  Clin Imaging       Date:  2015-07-26       Impact factor: 1.605

10.  Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Authors:  Maciej Juryńczyk; Brian Weinshenker; Gulsen Akman-Demir; Nasrin Asgari; David Barnes; Mike Boggild; Abhijit Chaudhuri; Marie D'hooghe; Nikos Evangelou; Ruth Geraldes; Zsolt Illes; Anu Jacob; Ho Jin Kim; Ingo Kleiter; Michael Levy; Romain Marignier; Christopher McGuigan; Katy Murray; Ichiro Nakashima; Lekha Pandit; Friedemann Paul; Sean Pittock; Krzysztof Selmaj; Jérôme de Sèze; Aksel Siva; Radu Tanasescu; Sandra Vukusic; Dean Wingerchuk; Damian Wren; Isabel Leite; Jacqueline Palace
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.